Literature DB >> 7940690

Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting.

C Yu1, E Ostrander, E Bryant, R Burnett, R Storb.   

Abstract

We have used a polymerase chain reaction-based assay measuring polymorphic (CA)n repeats, a class of simple sequence repeats, to assess the success of allogeneic canine marrow transplants. Results were compared with those obtained with karyotype analysis of dividing cells in recipients that were sex mismatched with their marrow donors. Twenty recipients were conditioned for transplantation of genotypically DLA-identical littermate marrow by 450 cGy of total-body irradiation. In 2 recipients, results could not be compared, since either only cytogenetic or dinucleotide (CA)n marker data existed. Both dogs had autologous marrow recovery. In 15 of the remaining 18 recipients, complete agreement was found between the results obtained with dinucleotide (CA)n markers, cytogenetic studies, and granulocyte changes after transplantation. Seven of the 15 showed eventual autologous recovery, 6 displayed mixtures of host and donor cells, and 2 showed donor-type hematopoiesis. Two of the 18 dogs showed mixed chimerism with (CA)n markers and autologous recovery by cytogenetics, findings that may be related to differences in cells analyzed by the two techniques--i.e., all nucleated cells by (CA)n markers versus dividing cells by cytogenetics. In one additional recipient, results of marrow cytogenetics, granulocyte changes, and (CA)n markers were consistent with a successful allograft, while peripheral blood cytogenetics suggested autologous recovery, possibly the result of erroneous blood sampling. Polymerase chain reaction-based testing for dinucleotide repeat (CA)n polymorphisms, originally developed for genetic mapping in the dog, is useful and reliable when compared with cytogenetic studies, in assessing the success of allogeneic marrow transplants in dogs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940690

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.

Authors:  Scott S Graves; Barry E Storer; Tiffany M Butts; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-28       Impact factor: 5.742

2.  Mixed chimerism renders residual host dendritic cells incapable of alloimmunization of the marrow donor in the canine model of allogeneic marrow transplantation.

Authors:  Steven L Rosinski; Scott S Graves; Deborah A Higginbotham; Rainer Storb
Journal:  Chimerism       Date:  2015-10-02

3.  Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation.

Authors:  Hirohisa Nakamae; Fabio R Kerbauy; D Scott Wilbur; Wolfgang Bethge; Donald K Hamlin; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Journal:  Transplantation       Date:  2010-06-15       Impact factor: 4.939

4.  Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.

Authors:  Scott S Graves; Maura H Parker; Diane Stone; George E Sale; Smitha P S Pillai; Melissa M Johnson; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-25       Impact factor: 5.742

5.  Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.

Authors:  Marco Mielcarek; Beverly Torok-Storb; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-08       Impact factor: 5.742

6.  Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.

Authors:  Marco Mielcarek; Rainer Storb; George E Georges; Ludmila Golubev; Alla Nikitine; Billanna Hwang; Richard A Nash; Beverly Torok-Storb
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-30       Impact factor: 5.742

7.  Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.

Authors:  Yun Chen; Brian Kornblit; Donald K Hamlin; George E Sale; Erlinda B Santos; D Scott Wilbur; Barry E Storer; Rainer Storb; Brenda M Sandmaier
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

8.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.

Authors:  Lauri Burroughs; Marco Mielcarek; Marie-Térèse Little; Gary Bridger; Ron Macfarland; Simon Fricker; Jean Labrecque; Brenda M Sandmaier; Rainer Storb
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

9.  Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

Authors:  R A Nash; M Yunosov; K Abrams; B Hwang; C Castilla-Llorente; P Chen; A S Farivar; G E Georges; R C Hackman; W J E Lamm; M Lesnikova; H D Ochs; J Randolph-Habecker; S F Ziegler; R Storb; B Storer; D K Madtes; R Glenny; M S Mulligan
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

10.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.